Atea Pharmaceuticals, Inc.
2'-substituted-N6-substituted purine nucleotides for RNA virus treatment

Abstract:

The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.